DA Davidson Maintains Buy on Cellebrite DI, Raises Price Target to $22

Benzinga · 1d ago
DA Davidson analyst Rudy Kessinger maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $20 to $22.